A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets

Clinical trial NCT04481607 · UNKNOWN

Trial details

NCT number: NCT04481607
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor or Hematologic Tumor

Start date: 2020-08-24
Primary completion: 2022-12-31
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.